OPRM1 and neoplasm: While the effects of opioids on tumor growth, progression, and metastasis via the mu-opioid receptor may be independent of the immune system [32], the effects of opioids on the immune system may play a role in patients receiving ICIs, and could explain why higher opioid use in our cohort was associated with even worse outcomes.